Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To explore the neuroanatomic basis of amnestic mild cognitive impairment (aMCI) in patients with Parkinson disease (PD; aMCI-PD+) and without PD (aMCI-PD−).
Methods: A total of 119 patients with aMCI (aMCI-PD−, n = 78, and aMCI-PD+, n = 41) underwent T1-weighted MRI, and the image data were analyzed using voxel-based morphometry.
Results: No significant differences in demographic characteristics or general cognition were found between patients with aMCI-PD− and aMCI-PD+. Comparisons of neuropsychological tests between groups revealed that patients with aMCI-PD− had lower scores in delayed verbal and visual recognition memory, whereas visuospatial dysfunction was more severe in patients with aMCI-PD+. Gray matter (GM) density in the right temporal and posterior cingular cortices was significantly lower in the aMCI-PD− group compared with controls. In contrast, GM density in the aMCI-PD+ group was significantly lower in the precuneus and left prefrontal and primary motor areas relative to controls. A direct comparison between groups showed that decreased GM density in aMCI-PD− relative to aMCI-PD+ was localized in the right temporal and anterior prefrontal areas, whereas decreased GM density in aMCI-PD+ relative to aMCI-PD− was involved in the bilateral precuneus, left primary motor, and right parietal areas. Memory decline was correlated with temporal area atrophy in aMCI-PD− and with posterior cingulate cortex atrophy in aMCI-PD+.
Conclusions: Our data suggest that different neuroanatomic systems underlie memory dysfunction in patients with aMCI-PD− and aMCI-PD+.
Footnotes
Study funding: Supported by Mid-career Researcher Program through NRF grant funded by the MEST (2010-0007749).
-
- AD
- Alzheimer disease
- ADL
- activities of daily living
- aMCI
- amnestic mild cognitive impairment
- aMCI-PD+
- patients with amnestic mild cognitive impairment with Parkinson disease
- aMCI-PD−
- patients with amnestic mild cognitive impairment without Parkinson disease
- CDR
- Clinical Dementia Rating
- COWAT
- Controlled Oral Word Association Test
- GM
- gray matter
- K-BNT
- Korean version of the Boston Naming Test
- MCI
- mild cognitive impairment
- PD
- Parkinson disease
- RCFT
- Rey Complex Figure Test
- SNSB
- Seoul Neuropsychological Screening Battery
- SVLT
- Seoul Verbal Learning Test
- UPDRS-III
- Unified Parkinson's Disease Rating Scale Part III
- VBM
- voxel-based morphometry
Supplemental data at www.neurology.org
- Received May 13, 2010.
- Accepted August 12, 2010.
- Copyright © 2010 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Anatomical heterogeneity of Alzheimer diseaseBased on cortical thickness on MRIsYoung Noh, Seun Jeon, Jong Min Lee et al.Neurology, October 24, 2014 -
Article
Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer DiseaseJoseph Therriault, Tharick A. Pascoal, Melissa Savard et al.Neurology, October 22, 2020 -
Articles
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiBS. M. Resnick, J. Sojkova, Y. Zhou et al.Neurology, February 10, 2010 -
Article
Tau PET in Alzheimer disease and mild cognitive impairmentHanna Cho, Jae Yong Choi, Mi Song Hwang et al.Neurology, June 29, 2016